| 名稱 | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocati |
| 型號(hào) | CBP20188D |
| 報(bào)價(jià) |  |
| 特點(diǎn) | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocation |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Translocation > CBP20188DAI-Edigene® FGFR2(E17)- BICC1(E3) Translocati
- 詳細(xì)內(nèi)容
CBP20188D | |
| Format | DNA |
| Description | FGFR2, fibroblast growth factor receptor 2, is a receptor tyrosine kinase activated upon binding of the FGF ligand, which activates RAS-MAPK and PI3K-AKT pathways. Altered function of FGFR2 through activating mutations, fusions, and amplification increases cell proliferation and tumorigenesis and is observed in prostate, breast, lung, uterine, and ovarian cancers, while FGFR2 amplification and overexpression is commonly observed in gastric cancer. |
| Technical Data | |
| Left Gene | FGFR2 |
| Left Breakpoint | chr10:1232****1:- (hg19) |
| Right Gene | BICC1 |
| Right Breakpoint | chr10:60****4:+ (hg19) |
| %AF | N/A |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">
會(huì)員_a.png)